October 13, 2024

Experts in Healthcare Unite in Support of Medicare’s Drug Price Negotiation Program

Zuckerman Spaeder has submitted an amicus brief opposing Merck’s legal challenge to the Drug Price Negotiation Program (DPNP), on behalf of nine healthcare and Medicare experts. The DPNP, established by the Inflation Reduction Act, gives the federal government the authority to bargain for the price of particular prescription medications, which is a crucial step in bringing down healthcare costs.

Click Here to Read More https://www.zuckerman.com/news/press-release/leading-healthcare-experts-oppose-lawsuit-challenging-medicares-drug-price-negotiation-program

Tags

Facebook
WhatsApp
Telegram
LinkedIn
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x